{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:23:01Z","timestamp":1794997381514,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04388-6","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T09:33:39Z","timestamp":1754991219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of sodium bicarbonate therapy on cognitive and cerebrovascular function in midlife and older adults with chronic kidney disease: a pilot randomized trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Fangning","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nell","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Reddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaf","family":"Hamour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Seals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Furgeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen L.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"4388_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.ajkd.2016.01.026","volume":"68","author":"M Kurella Tamura","year":"2016","unstructured":"Kurella Tamura M, Yaffe K, Hsu CY, Yang J, Sozio S, Fischer M, et al. Cognitive Impairment and Progression of CKD. Am J Kidney Dis 2016;68:77\u201383.","journal-title":"Am J Kidney Dis"},{"key":"4388_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/j.ajkd.2008.05.004","volume":"52","author":"M Kurella Tamura","year":"2008","unstructured":"Kurella Tamura M, Wadley V, Yaffe K, McClure LA, Howard G, Go R, et al. Kidney function and cognitive impairment in US adults: the reasons for geographic and racial differences in stroke (REGARDS) Study. Am J Kidney Dis 2008;52:227\u201334.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"4388_CR3","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1111\/j.1532-5415.2004.52508.x","volume":"52","author":"M Kurella","year":"2004","unstructured":"Kurella M, Chertow GM, Luan J, Yaffe K.Cognitive impairment in chronic kidney disease. J Am Geriatr Soc. 2004;52(11):1863\u201369.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"4388_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0272-6386(97)90563-1","volume":"30","author":"AR Sehgal","year":"1997","unstructured":"Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ.Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997;30(1):41\u201349.","journal-title":"Am J Kidney Dis"},{"key":"4388_CR5","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2215\/CJN.01960215","volume":"10","author":"MA McAdams-DeMarco","year":"2015","unstructured":"McAdams-DeMarco MA, Tan J, Salter ML, Gross A, Meoni LA, Jaar BG, et al. Frailty and cognitive function in incident hemodialysis patients. Clin J Am Soc Nephrol 2015;10:2181\u201389.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4388_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1053\/j.ajkd.2011.12.029","volume":"60","author":"EP Sorensen","year":"2012","unstructured":"Sorensen EP, Sarnak MJ, Tighiouart H, Scott T, Giang LM, Kirkpatrick B, et al. The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients. Am J Kidney Dis 2012;60:417\u201326.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"4388_CR7","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3349\/ymj.2013.54.6.1447","volume":"54","author":"S Jung","year":"2013","unstructured":"Jung S, Lee YK, Choi SR, Hwang SH, Noh JW.Relationship between cognitive impairment and depression in dialysis patients. Yonsei Med J. 2013;54(6):1447\u201353.","journal-title":"Yonsei Med J"},{"issue":"4","key":"4388_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/BF02895153","volume":"19","author":"BA Bremer","year":"1997","unstructured":"Bremer BA, Wert KM, Durica AL, Weaver A.Neuropsychological, physical, and psychosocial functioning of individuals with end-stage renal disease. Ann Behav Med. 1997;19(4):348\u201352.","journal-title":"Ann Behav Med"},{"key":"4388_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1681\/ASN.2008020159","volume":"20","author":"O Moranne","year":"2009","unstructured":"Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 2009;20:164\u201371.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"4388_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/nep.12315","volume":"19","author":"KL Raphael","year":"2014","unstructured":"Raphael KL, Zhang Y, Ying J, Greene T.Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease. Nephrology (Carlton). 2014;19(10):648\u201354.","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"4388_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/j.1523-1755.2004.00481.x","volume":"65","author":"JA Eustace","year":"2004","unstructured":"Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J.Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004;65(3):1031\u201340.","journal-title":"Kidney Int"},{"key":"4388_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ki.2015.52","volume":"88","author":"M Vallet","year":"2015","unstructured":"Vallet M, Metzger M, Haymann JP, Flamant M, Gauci C, Thervet E, et al. Urinary ammonia and long-term outcomes in chronic kidney disease. Kidney Int 2015;88:137\u201345.","journal-title":"Kidney Int"},{"issue":"12","key":"4388_CR13","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/sj.ki.5001905","volume":"70","author":"DE Wesson","year":"2006","unstructured":"Wesson DE.Regulation of kidney acid excretion by endothelins. Kidney Int. 2006;70(12):2066\u201373.","journal-title":"Kidney Int"},{"issue":"11","key":"4388_CR14","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ki.2012.267","volume":"82","author":"DE Wesson","year":"2012","unstructured":"Wesson DE, Jo CH, Simoni J.Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention. Kidney Int. 2012;82(11):1184\u201394.","journal-title":"Kidney Int"},{"issue":"5","key":"4388_CR15","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/ndt\/gfu388","volume":"30","author":"DE Wesson","year":"2015","unstructured":"Wesson DE, Jo CH, Simoni J.Angiotensin II-mediated GFR decline in subtotal nephrectomy is due to acid retention associated with reduced GFR. Nephrol Dial Transplant. 2015;30(5):762\u201370.","journal-title":"Nephrol Dial Transplant"},{"key":"4388_CR16","doi-asserted-by":"crossref","unstructured":"Wesson DE, Simoni J, Broglio K, Sheather S. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Am J Physiol Renal Physiol. 2011;300(4).","DOI":"10.1152\/ajprenal.00587.2010"},{"issue":"6","key":"4388_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11906-014-0431-2","volume":"16","author":"AC Montezano","year":"2014","unstructured":"Montezano AC, Nguyen Dinh Cat A, Rios FJ, Touyz RM.Angiotensin II and vascular injury. Curr Hypertens Rep. 2014;16(6):431.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"4388_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3317\/jraas.2004.025","volume":"5","author":"A Mahmud","year":"2004","unstructured":"Mahmud A, Feely J.Arterial stiffness and the renin-angiotensin-aldosterone system. J Renin Angiotensin Aldosterone Syst. 2004;5(3):102\u201308.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"4388_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.108.123612","volume":"53","author":"S Inaba","year":"2009","unstructured":"Inaba S, Iwai M, Furuno M, Tomono Y, Kanno H, Senba I, et al. Continuous activation of renin-angiotensin system impairs cognitive function in renin\/angiotensinogen transgenic mice. Hypertension 2009;53:356\u201362.","journal-title":"Hypertension"},{"issue":"6","key":"4388_CR20","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.ajkd.2004.07.022","volume":"44","author":"D Russo","year":"2004","unstructured":"Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE.Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004;44(6):1024\u201330.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"4388_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/jnc.14235","volume":"144","author":"MF Iulita","year":"2018","unstructured":"Iulita MF, Noriega de la Colina A, Girouard H.Arterial stiffness, cognitive impairment and dementia: confounding factor or real risk? J Neurochem. 2018;144(5):527\u201348.","journal-title":"J Neurochem"},{"key":"4388_CR22","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1212\/WNL.0b013e31823b4765","volume":"77","author":"C Helmer","year":"2011","unstructured":"Helmer C, Stengel B, Metzger M, Froissart M, Massy ZA, Tzourio C, et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology 2011;77:2043\u201351.","journal-title":"Neurology"},{"key":"4388_CR23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2215\/CJN.07050717","volume":"13","author":"M Dobre","year":"2018","unstructured":"Dobre M, Gaussoin SA, Bates JT, Chonchol MB, Cohen DL, Hostetter TH, et al. Serum bicarbonate concentration and cognitive function in hypertensive adults. Clin J Am Soc Nephrol 2018;13:596\u2013603.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"4388_CR24","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1681\/ASN.2008111205","volume":"20","author":"I de Brito-ashurst","year":"2009","unstructured":"de Brito-ashurst I, Varagunam M, Raftery MJ, Yaqoob MM.Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075\u201384.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4388_CR25","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2215\/CJN.08340812","volume":"8","author":"MK Abramowitz","year":"2013","unstructured":"Abramowitz MK, Melamed ML, Bauer C, Raff AC, Hostetter TH.Effects of oral sodium bicarbonate in patients with CKD. Clin J Am Soc Nephrol. 2013;8(5):714\u201320.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4388_CR26","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1681\/ASN.0000000000000161","volume":"34","author":"J Kendrick","year":"2023","unstructured":"Kendrick J, You Z, Andrews E, Farmer-Bailey H, Moreau K, Chonchol M, et al. Sodium bicarbonate treatment and vascular function in CKD: a randomized, double-blind, placebo-controlled trial. J Am Soc Nephrol 2023;34:1433\u201344.","journal-title":"J Am Soc Nephrol"},{"key":"4388_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1681\/ASN.2019030287","volume":"31","author":"KL Raphael","year":"2020","unstructured":"Raphael KL, Isakova T, Ix JH, Raj DS, Wolf M, Fried LF, et al. A randomized trial comparing the safety, adherence, and pharmacodynamics profiles of two doses of sodium bicarbonate in CKD: the base pilot trial. J Am Soc Nephrol 2020;31:161\u201374.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"4388_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1055\/s-0032-1331812","volume":"32","author":"S Purkayastha","year":"2012","unstructured":"Purkayastha S, Sorond F.Transcranial doppler ultrasound: technique and application. Semin Neurol. 2012;32(4):411\u201320.","journal-title":"Semin Neurol"},{"key":"4388_CR29","doi-asserted-by":"publisher","first-page":"e15561","DOI":"10.14814\/phy2.15561","volume":"11","author":"ES Oh","year":"2023","unstructured":"Oh ES, Freeberg KA, Steele CN, Wang W, Farmer-Bailey H, Coppock ME, et al. Cerebrovascular pulsatility index is higher in chronic kidney disease. Physiol Rep 2023;11:e15561.","journal-title":"Physiol Rep"},{"issue":"5","key":"4388_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/jhh.2015.76","volume":"30","author":"I Brar","year":"2016","unstructured":"Brar I, Robertson AD, Hughson RL.Increased central arterial stiffness and altered cerebrovascular haemodynamic properties in South Asian older adults. J Hum Hypertens. 2016;30(5):309\u201314.","journal-title":"J Hum Hypertens"},{"key":"4388_CR31","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1093\/brain\/awr253","volume":"134","author":"GF Mitchell","year":"2011","unstructured":"Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the age, gene\/environment susceptibility\u2013reykjavik study. Brain 2011;134:3398\u2013407.","journal-title":"Brain"},{"key":"4388_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/jcbfm.2013.180","volume":"34","author":"S Purkayastha","year":"2014","unstructured":"Purkayastha S, Fadar O, Mehregan A, Salat DH, Moscufo N, Meier DS, et al. Impaired cerebrovascular hemodynamics are associated with cerebral white matter damage. J Cereb Blood Flow Metab 2014;34:228\u201334.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"4388_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neurobiolaging.2013.08.026","volume":"35","author":"A Wahlin","year":"2014","unstructured":"Wahlin A, Ambarki K, Birgander R, Malm J, Eklund A.Intracranial pulsatility is associated with regional brain volume in elderly individuals. Neurobiol Aging. 2014;35(2):365\u201372.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"4388_CR34","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3233\/JAD-170349","volume":"60","author":"CP Chung","year":"2017","unstructured":"Chung CP, Lee HY, Lin PC, Wang PN.Cerebral artery pulsatility is associated with cognitive impairment and predicts dementia in individuals with subjective memory decline or mild cognitive impairment. J Alzheimers Dis. 2017;60(2):625\u201332.","journal-title":"J Alzheimers Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04388-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04388-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04388-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:38:54Z","timestamp":1757417934000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04388-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4388"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04388-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Colorado Multiple Institutional Review Board (COMIRB). All participants provided written informed consent before study entry. All authors declare adherence to the Declaration of Helsinki. The study was registered at ClinicalTrials.gov (NCT04600323) on 10\/19\/2020.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JK has received advisory fees from AstraZeneca. JK has received grant funding from NIH NIDDK, NHBLI, NIA, the Juvenile Diabetes Research Foundation, Bayer Healthcare, AstraZeneca, NovoNordisk, Pathalys and Fresenius Renal Therapies. All other authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"454"}}